Combining Daratumumab with VRd Improves Outcomes in Patients with Transplant-Ineligible or Transplant-Deferred Newly Diagnosed Multiple Myeloma By Ogkologos - March 3, 2025 634 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the CEPHEUS study Source RELATED ARTICLESMORE FROM AUTHOR FX-909 Demonstrates Acceptable Safety and Preliminary Antitumour Activity, Establishing a Proof of Concept for PPARγ Inverse Agonism in Advanced Urothelial Cancer Pimicotinib Shows Robust Antitumour Activity and Clinically Meaningful Improvements in Patients with Tenosynovial Giant Cell Tumour FDA Grants Accelerated Approval to Zongertinib for Unresectable or Metastatic Non-Squamous NSCLC MOST POPULAR Patient Guide on Cancer Pain Management Now Available Also in French December 16, 2025 Clinical Trials in Genitourinary Cancers: KEYNOTE-641, P3BEP, and PIVOT-09 August 20, 2020 Rediscovered Drugs Hit Leukemia from Two Different Angles July 21, 2020 Immunotherapy Prolongs Survival in Recurrent, Persistent or Metastatic Cervical Cancer [ESMO... September 18, 2021 Load more HOT NEWS For Women With Dense Breasts, An MRI May Be A Better... A vision for the next decade of UK life sciences Lung cancer screening can’t leave anyone in the UK behind Young Mom-of-Three Learns She Has Stage 4 Breast Cancer, 5 Days...
